Abiopharma

New Form 8-K - Precipio, Inc. Filed: 2025-08-18 AccNo: 0001104659-25-079859 Size: 2 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Beyond Air, Inc. Filed: 2025-08-18 AccNo: 0001641172-25-024647 Size: 358 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G - X4 Pharmaceuticals, Inc Filed: 2025-08-18 AccNo: 0001641172-25-024646 Size: 26 KB

Bausch + Lomb Announces Board Changes

New Form NT 10-Q - Accelerate Diagnostics, Inc Filed: 2025-08-18 AccNo: 0001104659-25-079857 Size: 40 KB

New Form SEC STAFF ACTION - Notable Labs, Ltd. Filed: 2025-08-18 AccNo: 9999999997-25-003361 Size: 3 KB

REGENXBIO Announces FDA Review Extension of BLA for RGX-121 to Treat Patients with MPS II

Nutex Health Inc. (NUTX) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

REGENXBIO Announces FDA Review Extension of BLA for RGX-121 to Treat Patients with MPS II

New Form 8-K - Accelerate Diagnostics, Inc Filed: 2025-08-18 AccNo: 0001104659-25-079855 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.03: Bankruptcy or Receivership Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits

New Form 144 - INSMED Inc Filed: 2025-08-18 AccNo: 0002007317-25-000896 Size: 9 KB

New Form SCHEDULE 13G - Syndax Pharmaceuticals Inc Filed: 2025-08-18 AccNo: 0000902664-25-003741 Size: 16 KB

New Form 144 - Atara Biotherapeutics, Inc. Filed: 2025-08-18 AccNo: 0000905148-25-003038 Size: 4 KB

Victor Miriame adjusted position in 0 shares of REVVITY, INC. (RVTY) Filed: 2025-08-18 AccNo: 0001193125-25-182734 Size: 5 KB

New Form 144 - COLLEGIUM PHARMACEUTICAL, INC Filed: 2025-08-18 AccNo: 0001959173-25-005316 Size: 5 KB